| Date | Title | Description |
| 30.07.2021 | CliniRx Becomes a Medidata Rave EDC Accredited Partner | SINGAPORE and NEW DELHI, July 30, 2021 /PRNewswire/ -- CliniRx has achieved accreditation as a CRO partner for Medidata Rave EDC, joining Medidata's industry-leading partner program to further advance its technical and operational performan... |
| 14.05.2021 | myMedidata Wins 'Best Patient Portal' Award in 2021 MedTech Breakthrough Awards Program | SINGAPORE, May 14, 2021 /PRNewswire/ -- Medidata, a Dassault Systèmes company, the global leader in creating end-to-end solutions supporting the entire clinical trial process, today announced that its myMedidata solution has been selected a... |
| 15.02.2018 | Why taking a consumer marketing approach can drive healthier behavior change | Modern, consumer-focused marketing already utilizes such personal data to deliver precise, targeted ads at the right time and in the right context. What if healthcare organizations could use this same information to help patients live healt... |
| 09.02.2018 | What’s the future of clinical trial design? Medidata sees a blend of virtual and in-person components | Medidata’s fourth-quarter earnings call offered a glimpse of how the company, which develops cloud-based technology and analytics tools to plan and execute clinical studies, envisions the future of clinical trial design. Glen De Vries, cofo... |
| 22.05.2017 | Medidata wants to help control your single-arm clinical trials | Amid the noise, New York City-based Medidata will be presenting new evidence to support the use of so-called “synthetic control arms” or SCAs, which address a major limitation in clinical trial designs.
According to a company statement, “Me... |
| 28.12.2016 | Healthcare deals I’d like to see in 2017: IBM buys Medidata, Comcast buys Doctor on Demand | Most of the digital health deals this year did not involve transactions across sectors so much as diversifying product offerings within digital health subsectors to target a wider customer base. And yet, I can take comfort from the fact tha... |
| 09.11.2016 | What’s the sweet spot for digital health collaborations with pharma clinical studies? | “We see an enormous challenge with consumer-grade devices because they can create a lot of noise in clinical studies,” he said.
Although there’s an obvious benefit to assessing patients’ health in the context of their daily lives, as oppose... |
| 02.05.2016 | MedData acquires patient engagement company Duet Health | Brecksville, Ohio-based healthcare services company MedData (not to be confused with Medidata) has acquired Columbus, Ohio-based patient engagement company Duet Health.
“This is a game changer for our clients,” MedData CEO Ann Barnes said i... |
| 14.02.2016 | The New Face Of Behavior Change | Glen de Vries Contributor
Glen de Vries is the president and co-founder of Medidata, a provider of cloud-based solutions for clinical research in life sciences.
In 1994, I eagerly accepted my first full-time position in research at the Colu... |
| 11.02.2016 | Morning Read: Mylan acquires Sweden’s Meda for $9.9B, pharmacists fight opioid addiction | Pharmacists have become de facto “drug cops” in the fight against opioid abuse. Some are actually comfortable with the role. — STAT
A global coalition of nearly three dozen medical journals, NGOs and research funders (think NIH, the Wellcom... |
| 27.08.2015 | NYC Rises As A Hub For Software-As-A-Service Startups | Brad Svrluga Contributor
Brad is a co-founder and General Partner at Primary Venture Partners.
Debating the importance of Software-as-a-Service long ago became a great way to flag yourself as a luddite.
The enterprise software market has be... |
| 17.04.2015 | How wearables and mobile health tech are reshaping clinical trials | Life science companies are continuously looking for ways to advance clinical research while simultaneously improving the understanding of drugs they are developing. One of the biggest issues for researchers is the high failure rate of new d... |
| 17.04.2015 | How wearables and mobile health tech are reshaping clinical trials | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Life science companies are continuously looking for ways to advance clinical research while simultaneously improving the understanding ... |
| 02.04.2014 | The best of clinical trial engagement apps leverage social, rewards, predictive analytics | Clinical trials cost drug companies a lot of money and can experience delays or even higher costs when patients drop out.
A challenge sponsored by Eli Lilly, UBC, Enlight Biosciences and the Partnerships in Clinical Trials meeting asked dev... |
| 15.10.2013 | Why this company’s IPO is a huge win for enterprise SaaS and health IT | Enterprise software is changing in many ways. It’s moving to the cloud. Profit margins are getting squeezed. Customers are cutting costs and demanding more. The onus is now on vendors to prove their value-add.
Sometimes the best way to buil... |
| 15.10.2013 | Why this company’s IPO is a huge win for enterprise SaaS and health IT | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Enterprise software is changing in many ways. It’... |
| 15.03.2012 | Medidata Gains Raves on Wall Street for Drug Development Tools | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
A molecular biologist and a urologist were sitting at a lab bench at Columbia Presbyterian hospital in New York in the mid-1990s musing about a problem they saw in drug develo... |
| 01.07.2009 | Exit market warms with five IPOs in Q2 | With five venture-backed public offerings, the second quarter was a significant improvement over the first quarter’s zero IPOs. In fact, this is the best the market has performed since the first quarter of 2008. That said, the number still ... |
| 03.06.2009 | Medidata continues IPO thaw, looks to raise $86M | Medidata Solutions, a company that streamlines clinical development and research processes for biotech firms, announced the terms of its IPO today — setting its price per share at $11 to $13 for 6.3 million shares. The sale could generate a... |
| - | The best of clinical trial engagement apps leverage social, rewards, predictive analytics | Clinical trials cost drug companies a lot of money and can experience delays or even higher costs when patients drop out.
A challenge sponsored by Eli Lilly, UBC, Enlight Biosciences and the Partnerships in Clinical Trials meeting asked dev... |
| - | Healthcare deals I’d like to see in 2017: IBM buys Medidata, Comcast buys Doctor on Demand | As we approach the waning days of 2016, it’s clear to me that my prognosticating skills leave much to be desired. I was 0/10 for my 2016 digital health predictions, barring any last-minute announcements.
My biggest blunder with those, albei... |
| - | What’s the sweet spot for digital health collaborations with pharma clinical studies? | This week’s news that Takeda Pharmaceuticals inked a deal with Koneksa Health, a digital health startup that uses wearables and connected devices to gather patient data, reinforces the point that pharma companies have found a place for digi... |
| - | What’s the future of clinical trial design? Medidata sees a blend of virtual and in-person components | Medidata’s fourth-quarter earnings call offered a glimpse of how the company, which develops cloud-based technology and analytics tools to plan and execute clinical studies, envisions the future of clinical trial design. Glen De Vries, cofo... |
| - | Why taking a consumer marketing approach can drive healthier behavior change | Patients are more than the sum of their diseases — a patient’s health problems interact with everything else in his life, from his job and home life to his diet and pastimes. But when providers meet with patients, it’s difficult to see ever... |
| - | Morning Read: Mylan acquires Sweden’s Meda for $9.9B, pharmacists fight opioid addiction | TOP STORIES
Three months after being spurned by Perrigo, generic drug giant Mylan is acquiring specialty pharma company Meda, of Solna, Sweden, for $9.9 billion. About $5.7 billion of the sum is in cash; the rest is in assumption of debt. —... |
| - | Medidata wants to help control your single-arm clinical trials | At the start of June, more than 30,000 oncology experts will flood into Chicago for the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.
The focus, as always, will be on data from the most exciting cancer drugs and tests. E... |
